The relationship between SLC22A8 expression levels and the clinicopathological characteristics of ccRCC was analyzed using the chi-square test, Fisher exact test, and Wilcoxon signed rank-sum test. Here, SLC22A8 is linked to nonpapillary renal cell carcinoma.